Alva Review-Courier -

Exec pushes back against drug hike 'moral requirement' quote


September 14, 2018

KANSAS CITY, Mo. (AP) — The head of a small Kansas City pharmaceutical company is defending himself after a financial publication reported that he said he had a "moral requirement" to raise the price of a 65-year-old antibiotic by 400 percent.

Nostrum Laboratories founder Nirmal Mulye said his comments to the London-based Financial Times were taken out of context, The Kansas City Star reports. The Financial Times has said it sticks by its story, which led to a sharp rebuke from Food and Drug Administration Commissioner Scott Gottlieb and others. Mulye said he has received threats.

At issu...

For access to this article please sign in or subscribe.


Reader Comments


Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2018